Journal of Advanced Research-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2187656, encodeId=b8ac218e656d2, content=一个多月意见回来，一共3个审稿人，两个评价比较中性，也提个10多个中肯的问题。另外一个就说了句要重新写方法部分，估计后面会有新问题。编辑给了大修，这样机会大不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Fri Feb 16 14:24:56 CST 2024, time=2024-02-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2245180, encodeId=cb3922451804b, content=偏重的研究方向：医学 经验分享：24.12.26with editor！希望送审求求！等了很久的技术审查了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=接心软审稿人！, createdTime=Fri Dec 27 15:53:08 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227742, encodeId=a537222e74243, content=9.22 With Editor 编辑好人一生平安，求求送审吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Sep 26 07:12:40 CST 2024, time=2024-09-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省)]

2024-02-16 ms4000000771872851 来自浙江省

一个多月意见回来，一共3个审稿人，两个评价比较中性，也提个10多个中肯的问题。另外一个就说了句要重新写方法部分，估计后面会有新问题。编辑给了大修，这样机会大不大。

437 18

展开18条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187656, encodeId=b8ac218e656d2, content=一个多月意见回来，一共3个审稿人，两个评价比较中性，也提个10多个中肯的问题。另外一个就说了句要重新写方法部分，估计后面会有新问题。编辑给了大修，这样机会大不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Fri Feb 16 14:24:56 CST 2024, time=2024-02-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2245180, encodeId=cb3922451804b, content=偏重的研究方向：医学 经验分享：24.12.26with editor！希望送审求求！等了很久的技术审查了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=接心软审稿人！, createdTime=Fri Dec 27 15:53:08 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227742, encodeId=a537222e74243, content=9.22 With Editor 编辑好人一生平安，求求送审吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Sep 26 07:12:40 CST 2024, time=2024-09-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省)]

2024-04-10 ms2000000076814193 来自浙江省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：细胞生物学;急危重病
经验分享：2024.2.2投稿
技术审查10天
with editor 3天
2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天）
2024.3.26修回
2024.4.7接收

感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。

95 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187656, encodeId=b8ac218e656d2, content=一个多月意见回来，一共3个审稿人，两个评价比较中性，也提个10多个中肯的问题。另外一个就说了句要重新写方法部分，估计后面会有新问题。编辑给了大修，这样机会大不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Fri Feb 16 14:24:56 CST 2024, time=2024-02-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2245180, encodeId=cb3922451804b, content=偏重的研究方向：医学 经验分享：24.12.26with editor！希望送审求求！等了很久的技术审查了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=接心软审稿人！, createdTime=Fri Dec 27 15:53:08 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227742, encodeId=a537222e74243, content=9.22 With Editor 编辑好人一生平安，求求送审吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Sep 26 07:12:40 CST 2024, time=2024-09-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省)]

2024-11-18 ms6000001210637983 来自加利福尼亚

我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊

23 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187656, encodeId=b8ac218e656d2, content=一个多月意见回来，一共3个审稿人，两个评价比较中性，也提个10多个中肯的问题。另外一个就说了句要重新写方法部分，估计后面会有新问题。编辑给了大修，这样机会大不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Fri Feb 16 14:24:56 CST 2024, time=2024-02-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2245180, encodeId=cb3922451804b, content=偏重的研究方向：医学 经验分享：24.12.26with editor！希望送审求求！等了很久的技术审查了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=接心软审稿人！, createdTime=Fri Dec 27 15:53:08 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227742, encodeId=a537222e74243, content=9.22 With Editor 编辑好人一生平安，求求送审吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Sep 26 07:12:40 CST 2024, time=2024-09-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省)]

2024-12-27 接心软审稿人！来自上海

偏重的研究方向：医学
经验分享：24.12.26with editor！希望送审求求！等了很久的技术审查了

7 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187656, encodeId=b8ac218e656d2, content=一个多月意见回来，一共3个审稿人，两个评价比较中性，也提个10多个中肯的问题。另外一个就说了句要重新写方法部分，估计后面会有新问题。编辑给了大修，这样机会大不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Fri Feb 16 14:24:56 CST 2024, time=2024-02-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2245180, encodeId=cb3922451804b, content=偏重的研究方向：医学 经验分享：24.12.26with editor！希望送审求求！等了很久的技术审查了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=接心软审稿人！, createdTime=Fri Dec 27 15:53:08 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227742, encodeId=a537222e74243, content=9.22 With Editor 编辑好人一生平安，求求送审吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Sep 26 07:12:40 CST 2024, time=2024-09-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省)]

2024-11-28 ms4000000276779176 来自上海

偏重的研究方向：医学
经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了

11 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187656, encodeId=b8ac218e656d2, content=一个多月意见回来，一共3个审稿人，两个评价比较中性，也提个10多个中肯的问题。另外一个就说了句要重新写方法部分，估计后面会有新问题。编辑给了大修，这样机会大不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Fri Feb 16 14:24:56 CST 2024, time=2024-02-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2245180, encodeId=cb3922451804b, content=偏重的研究方向：医学 经验分享：24.12.26with editor！希望送审求求！等了很久的技术审查了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=接心软审稿人！, createdTime=Fri Dec 27 15:53:08 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227742, encodeId=a537222e74243, content=9.22 With Editor 编辑好人一生平安，求求送审吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Sep 26 07:12:40 CST 2024, time=2024-09-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省)]

2024-09-26 白衣13 来自新南威尔士

9.22 With Editor 编辑好人一生平安，求求送审吧！

30 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187656, encodeId=b8ac218e656d2, content=一个多月意见回来，一共3个审稿人，两个评价比较中性，也提个10多个中肯的问题。另外一个就说了句要重新写方法部分，估计后面会有新问题。编辑给了大修，这样机会大不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Fri Feb 16 14:24:56 CST 2024, time=2024-02-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2245180, encodeId=cb3922451804b, content=偏重的研究方向：医学 经验分享：24.12.26with editor！希望送审求求！等了很久的技术审查了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=接心软审稿人！, createdTime=Fri Dec 27 15:53:08 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227742, encodeId=a537222e74243, content=9.22 With Editor 编辑好人一生平安，求求送审吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Sep 26 07:12:40 CST 2024, time=2024-09-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省)]

2022-01-18 ms3000001224934147

求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？

147 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187656, encodeId=b8ac218e656d2, content=一个多月意见回来，一共3个审稿人，两个评价比较中性，也提个10多个中肯的问题。另外一个就说了句要重新写方法部分，估计后面会有新问题。编辑给了大修，这样机会大不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Fri Feb 16 14:24:56 CST 2024, time=2024-02-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2245180, encodeId=cb3922451804b, content=偏重的研究方向：医学 经验分享：24.12.26with editor！希望送审求求！等了很久的技术审查了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=接心软审稿人！, createdTime=Fri Dec 27 15:53:08 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227742, encodeId=a537222e74243, content=9.22 With Editor 编辑好人一生平安，求求送审吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Sep 26 07:12:40 CST 2024, time=2024-09-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省)]

2024-12-09 ms9000000123620406 来自陕西省

偏重的研究方向：农林科学;食品毒理
经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要

18 0

[GetPortalCommentsPageByObjectIdResponse(id=2187656, encodeId=b8ac218e656d2, content=一个多月意见回来，一共3个审稿人，两个评价比较中性，也提个10多个中肯的问题。另外一个就说了句要重新写方法部分，估计后面会有新问题。编辑给了大修，这样机会大不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Fri Feb 16 14:24:56 CST 2024, time=2024-02-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2245180, encodeId=cb3922451804b, content=偏重的研究方向：医学 经验分享：24.12.26with editor！希望送审求求！等了很久的技术审查了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=接心软审稿人！, createdTime=Fri Dec 27 15:53:08 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227742, encodeId=a537222e74243, content=9.22 With Editor 编辑好人一生平安，求求送审吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Sep 26 07:12:40 CST 2024, time=2024-09-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省)]

2024-11-26 ms4000001186611146 来自山东省

大家Pending Technical Assessment这个状态持续多久啊？

14 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187656, encodeId=b8ac218e656d2, content=一个多月意见回来，一共3个审稿人，两个评价比较中性，也提个10多个中肯的问题。另外一个就说了句要重新写方法部分，估计后面会有新问题。编辑给了大修，这样机会大不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Fri Feb 16 14:24:56 CST 2024, time=2024-02-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2237562, encodeId=581b223e5620e, content=我想问问，这个杂志有WA状态吗，我都没看到WA状态就直接under review了，这个杂志是没有这个状态还是啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b00b8485313, createdName=ms6000001210637983, createdTime=Mon Nov 18 12:55:04 CST 2024, time=2024-11-18, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2245180, encodeId=cb3922451804b, content=偏重的研究方向：医学 经验分享：24.12.26with editor！希望送审求求！等了很久的技术审查了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=接心软审稿人！, createdTime=Fri Dec 27 15:53:08 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239743, encodeId=968b2239e4327, content=偏重的研究方向：医学 经验分享：11.19号投的，现在还在技术审查，为什么有的人技术审查那么快啊！想发邮件催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202412/aaa1d036ee7049f1b285567a69a3a307-0SuAUWhRaVlW.jpg, createdBy=5cb88522360, createdName=ms4000000276779176, createdTime=Thu Nov 28 16:07:20 CST 2024, time=2024-11-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227742, encodeId=a537222e74243, content=9.22 With Editor 编辑好人一生平安，求求送审吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Sep 26 07:12:40 CST 2024, time=2024-09-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241526, encodeId=dd9a224152684, content=偏重的研究方向：农林科学;食品毒理 经验分享：各位想问一下，是所有方向都需要提供3份WB原始数据吗，这个是不是技术审查人员需要而不是审稿人需要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14769391526, createdName=ms9000000123620406, createdTime=Mon Dec 09 14:49:03 CST 2024, time=2024-12-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2239306, encodeId=23cd2239306bd, content=大家Pending Technical Assessment这个状态持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90538125585, createdName=ms4000001186611146, createdTime=Tue Nov 26 14:49:30 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238368, encodeId=d19022383688f, content=偏重的研究方向：肿瘤;代谢;药学 经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Nov 22 10:14:09 CST 2024, time=2024-11-22, status=1, ipAttribution=江苏省)]

2024-11-22 第五先生来自江苏省

偏重的研究方向：肿瘤;代谢;药学
经验分享：大家知道这个杂志，投稿必须所有人都点击确认共同作者之后才会送审吗？？看到了投稿成功后邮件发过来，但是每个人点需要好久哦，并且还有不同单位的作者，联系起来比较麻烦

23 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务